SCPH(SCPH)
SCPH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $128M | $186M | $242M | $296M |
| Low | $111M | $172M | $223M | $273M |
| High | $145M | $200M | $260M | $318M |
| EBITDA Avg | $26M | $37M | $48M | $59M |
| Low | $22M | $34M | $45M | $55M |
| High | $29M | $40M | $52M | $64M |
| EBIT Avg | $26M | $37M | $48M | $59M |
| Low | $22M | $34M | $45M | $55M |
| High | $29M | $40M | $52M | $64M |
| Net Income Avg | $-9M | $37M | $56M | $81M |
| Low | $-20M | $12M | $51M | $73M |
| High | $9M | $67M | $62M | $89M |
| EPS Avg | $-0.16 | $0.67 | $1.27 | $1.82 |
| Low | $-0.45 | $0.28 | $1.14 | $1.63 |
| High | $0.20 | $1.50 | $1.39 | $1.99 |
| Analysts (Rev / EPS) | 3 / 3 | 4 / 4 | 2 / 3 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $31M | $35M | $37M | $38M | $40M | $43M |
| Low | $31M | $35M | $37M | $38M | $40M | $43M |
| High | $31M | $35M | $37M | $38M | $40M | $43M |
| EBITDA Avg | $6M | $7M | $7M | $8M | $8M | $9M |
| Low | $6M | $7M | $7M | $8M | $8M | $9M |
| High | $6M | $7M | $7M | $8M | $8M | $9M |
| EBIT Avg | $6M | $7M | $7M | $8M | $8M | $9M |
| Low | $6M | $7M | $7M | $8M | $8M | $9M |
| High | $6M | $7M | $7M | $8M | $8M | $9M |
| Net Income Avg | $-3M | $-268,598 | $3M | $3M | $5M | $8M |
| Low | $-3M | $-268,598 | $3M | $3M | $5M | $8M |
| High | $-3M | $-268,598 | $3M | $3M | $5M | $8M |
| EPS Avg | $-0.07 | $-0.01 | $0.05 | $0.05 | $0.09 | $0.14 |
| Low | $-0.07 | $-0.01 | $0.05 | $0.05 | $0.09 | $0.14 |
| High | $-0.07 | $-0.01 | $0.05 | $0.05 | $0.09 | $0.14 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |